Middlefield Banc (MBCN) EVP Receives 853 Shares via Vesting on 08/06/2025
Rhea-AI Filing Summary
Courtney M. Erminio, EVP and Chief Risk Officer of Middlefield Banc Corp (MBCN), reported the vesting and acquisition of restricted common stock on 08/06/2025. The filing shows 853 shares were acquired upon vesting at a reported price of $27.11 per share. The report notes that some holdings include shares from Middlefield's Dividend Reinvestment Plan and shares held jointly with a spouse.
The filing also discloses outstanding conditional stock awards that convert to common shares on future vesting dates: 1,628 shares vesting 03/10/2026, 1,708 shares vesting 09/06/2027, and 2,828 shares vesting 01/14/2028. The Form 4 was signed via power of attorney on 08/07/2025.
Positive
- 853 shares vested and were acquired by the reporting officer on 08/06/2025 at $27.11 per share
- Multiple conditional awards remain outstanding with clear vesting dates (1,628; 1,708; 2,828 shares), showing continued alignment of executive compensation with company performance/time
- Dividend Reinvestment Plan participation increases insider ownership via reinvestment rather than cash distributions
Negative
- None.
Insights
TL;DR: Routine insider vesting modestly increases holdings; no sale or material change reported.
The filing documents a time- and performance-based vesting event rather than an open-market purchase or sale. 853 shares vested at $27.11, which increases the reporting officer's direct holdings. The presence of a Dividend Reinvestment Plan component and joint holdings are administrative details that slightly affect reported beneficial ownership but do not indicate a change in corporate control or a liquidity event. Overall, this is a standard compensation-related equity event with limited immediate market impact.
TL;DR: Equity compensation and scheduled restricted awards disclosed; filings show standard governance and disclosure processes.
The Form 4 discloses vesting of restricted stock and multiple conditional awards with explicit vesting schedules (03/10/2026, 09/06/2027, 01/14/2028). The explanation references prior Form 8-K documentation for performance conditions, indicating consistent disclosure practices. The signature executed by power of attorney on 08/07/2025 is properly noted. There are no indications of unusual transfer mechanisms or departures from typical insider reporting requirements.